HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Fumihiro Oshita Selected Research

nedaplatin

12/2015Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910.
2/2013Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.
4/2012Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung.
1/2012Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
1/2011Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.
8/2008Phase II study of nedaplatin and irinotecan followed by gefitinib for elderly patients with unresectable non-small cell lung cancer.
1/2007Feasible combination chemotherapy with nedaplatin and irinotecan for patients with non-small cell lung cancer and multiple high-risk factors.
12/2004Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer.
7/2003Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Fumihiro Oshita Research Topics

Disease

19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 07/2003
18Neoplasms (Cancer)
11/2014 - 01/2002
7Lung Neoplasms (Lung Cancer)
11/2014 - 05/2004
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2014 - 03/2002
7Neutropenia
03/2013 - 07/2003
6Adenocarcinoma
11/2014 - 01/2002
5Carcinoma (Carcinomatosis)
06/2014 - 01/2011
3Pneumonia (Pneumonitis)
02/2013 - 08/2007
3Diarrhea
02/2013 - 07/2003
3Disease Progression
01/2012 - 08/2007
3Anemia
08/2008 - 08/2005
2Neoplasm Metastasis (Metastasis)
10/2015 - 02/2008
2Fatigue
02/2013 - 02/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2015
1Neuroendocrine Carcinoma
06/2014
1Hypotension (Low Blood Pressure)
02/2013
1Vomiting
02/2013
1Oral Hemorrhage
02/2013
1Hyponatremia
02/2013
1Fever (Fevers)
01/2013
1Vasculitis (Vasculitides)
01/2013
1Hypersensitivity (Allergy)
02/2010
1Anorexia
02/2010
1Cicatrix (Scar)
01/2009
1Leukopenia
08/2007
1Infection
08/2005
1Pleurisy (Pleuritis)
04/2004
1Myocardial Infarction
07/2003

Drug/Important Bio-Agent (IBA)

17irinotecan (Camptosar)FDA LinkGeneric
12/2015 - 07/2003
9nedaplatinIBA
12/2015 - 07/2003
5Cisplatin (Platino)FDA LinkGeneric
06/2014 - 04/2004
5Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 01/2004
5Complementary DNA (cDNA)IBA
10/2006 - 05/2004
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
01/2013 - 07/2002
3gefitinib (Iressa)FDA Link
01/2012 - 08/2008
3CD29 AntigensIBA
08/2004 - 03/2002
2Adenocarcinoma of lungIBA
10/2015 - 01/2009
2Proteins (Proteins, Gene)IBA
11/2014 - 09/2010
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2014 - 01/2010
2CreatinineIBA
03/2013 - 08/2005
2amrubicinIBA
03/2013 - 01/2008
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2013 - 08/2008
2Alanine Transaminase (SGPT)IBA
02/2010 - 08/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2004 - 01/2002
2CyclinsIBA
08/2004 - 01/2003
2Cyclin D1IBA
08/2004 - 01/2003
1docetaxel (Taxotere)FDA Link
01/2015
1bevacizumabFDA Link
01/2015
1CalnexinIBA
11/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1ParaffinIBA
01/2014
1Formaldehyde (Formol)FDA Link
01/2014
1UracilIBA
03/2013
1TegafurIBA
03/2013
1erlotinib (CP 358,774)FDA Link
01/2012
1anaplastic lymphoma kinaseIBA
09/2010
1Biological Markers (Surrogate Marker)IBA
09/2010
1BilirubinIBA
08/2007
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
10/2006
1InterferonsIBA
10/2006
1TubulinIBA
10/2006
1Cyclin-Dependent Kinase 8IBA
10/2006
1PlatinumIBA
08/2005
1vinorelbine (Navelbine)FDA LinkGeneric
08/2004
1gemcitabineFDA Link
04/2004
1PicibanilIBA
04/2004
1CamptothecinIBA
01/2004
1taxaneIBA
01/2004
1retinoic acid receptor betaIBA
01/2003
1Cyclin EIBA
01/2003
1A-factor (Streptomyces)IBA
07/2002
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2002

Therapy/Procedure

18Drug Therapy (Chemotherapy)
12/2015 - 03/2002
9Combination Drug Therapy (Combination Chemotherapy)
07/2013 - 07/2003
1Lasers (Laser)
11/2014
1Adjuvant Chemotherapy
06/2014
1Aftercare (After-Treatment)
01/2012
1Radiotherapy
08/2004